secwatch.observer — SEC 8-K summary
======================================

Issuer:     MAIA Biotechnology, Inc. (MAIA)
CIK:        0001878313
Form:       8-K
Filed at:   2023-05-30T23:59:59+00:00
Accession:  0001564590-23-007471
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

MAIA Biotechnology stockholders re-elect directors, ratify auditor, approve equity plan amendment
--------------------------------------------------------------------------------

- Re-elected Class I directors Louie Ngar Yee and Steven Chaouki with >6M votes each; 352k broker non-votes.
- Ratified Grant Thornton as independent auditor for FY2023: 6,502,742 for, 3,091 against, 63 abstain.
- Approved amendment to 2021 Equity Incentive Plan allowing annual share increase of 10% of fully diluted outstanding through 2032.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1878313/000156459023007471/0001564590-23-007471-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1878313/000156459023007471/maia-8k_20230525.htm
  HTML page:      https://secwatch.observer/filing/0001564590-23-007471

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer